S. Marcotullio

发表

The Less Drugs Regimens (LDRs) therapy approach in HIV-1: an Italian expert panel perspective for the long-term management of HIV-1 infection.

A. d’Arminio Monforte, G. Ippolito, A. Lazzarin, 2012, The new microbiologica.

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011.

M. Moroni, A. d’Arminio Monforte, A. Lazzarin, 2011, The new microbiologica.

A patient-centred approach to deprescribing antiretroviral therapy in people living with HIV.

J. Milic, C. Mussini, G. Guaraldi, 2020, The Journal of antimicrobial chemotherapy.

Renal complications in HIV disease: between present and future.

P. Narciso, L. Calza, C. Mussini, 2012, AIDS reviews.

Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL.

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2019, The Journal of antimicrobial chemotherapy.

Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2013, The Journal of antimicrobial chemotherapy.

Rate and predictors of self-chosen drug discontinuations in highly active antiretroviral therapy-treated HIV-positive individuals.

A. Wu, G. Guaraldi, R. Murri, 2009, AIDS patient care and STDs.

Evidence-based renewal of the Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons.

A. d’Arminio Monforte, A. Lazzarin, A. Antinori, 2018, The new microbiologica.

Communication, recruitment and enrolment in the preventative and therapeutic phase I clinical trial against HIV/AIDS based on the recombinant HIV-1 Tat protein

S. Bellino, B. Ensoli, A. Luzi, 2011, AIDS care.

Increased incidence of sexually transmitted diseases in the recent years: data from the ICONA cohort

A. d’Arminio Monforte, A. Antinori, G. Guaraldi, 2014, Journal of the International AIDS Society.

Viro-immunological dynamics in HIV-1-infected subjects receiving once-a-week emtricitabine to delay treatment change after failure: a pilot randomised trial.

E. Seminari, A. Lazzarin, L. Galli, 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2016.

A. d’Arminio Monforte, A. Lazzarin, A. Antinori, 2017, The new microbiologica.

Is "once-daily" regimen a key strategy for improving adherence to antiretroviral regimens?

R. Murri, S. Marcotullio, F. von Schloesser, 2006, Journal of acquired immune deficiency syndromes.

Long-acting agents for HIV infection: biological aspects, role in treatment and prevention, and patient's perspective.

A. Cingolani, S. Marcotullio, S. Rusconi, 2017, The new microbiologica.

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons.

M. Moroni, A. d’Arminio Monforte, A. Lazzarin, 2011, The new microbiologica.

Therapeutic Immunization with HIV-1 Tat Reduces Immune Activation and Loss of Regulatory T-Cells and Improves Immune Function in Subjects on HAART

A. Lazzarin, O. Picconi, C. Mussini, 2010, PloS one.

Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2018, The Journal of antimicrobial chemotherapy.

Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2019, BMC Public Health.

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

Karin J. Metzner, Huldrych F. Günthard, E. Nicastri, 2014, The Journal of antimicrobial chemotherapy.

The Management of Geriatric and Frail HIV Patients. A 2017 Update from the Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic-Clinical Management of HIV-1 Infected Persons

C. Mussi, M. Cesari, A. d’Arminio Monforte, 2018, The Journal of Frailty & Aging.

Less drug regimens and PI/r-based strategies in HIV infection: focus on best practices using the HIV patient's journey methodology.

A. d’Arminio Monforte, G. Ippolito, A. Lazzarin, 2014, The new microbiologica.

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2015.

A. d’Arminio Monforte, A. Lazzarin, A. Antinori, 2016, The new microbiologica.

Challenges in HIV Vaccine Research for Treatment and Prevention

P. Monini, B. Ensoli, F. Ensoli, 2014, Front. Immunol..

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: data from the Icona Foundation cohort

A. d’Arminio Monforte, A. Antinori, G. Guaraldi, 2015, HIV medicine.

1329. Experiences and Emotional Challenges of Antiretroviral Treatment (ART)—Findings from the Positive Perspectives Study

A. Ustianowski, S. Marcotullio, Y. Punekar, 2019, Open Forum Infectious Diseases.

Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2018, BMC Medicine.

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update December 2014.

A. d’Arminio Monforte, A. Lazzarin, A. Antinori, 2015, The new microbiologica.

An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project.

A. d’Arminio Monforte, R. Bruno, A. Lazzarin, 2015, The new microbiologica.

First‐line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, A. Lazzarin, 2018, HIV medicine.

Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus.

A. d’Arminio Monforte, F. Ceccherini‐Silberstein, G. Ippolito, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

The Management of Geriatric and Frail HIV Patients. A 2017 Update from the Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic-Clinical Management of HIV-1 Infected Persons

J. Milic, G. Guaraldi, M. Andreoni, 2018, The Journal of Frailty & Aging.